Charles River Laboratories

Charles River Laboratories

CRL · NYSE
CRL · NYSE
315.43
USD-13.32-4.05%

Latest News

    @eWhispers
    eWhispers

    #earnings before the open tomorrow https://t.co/lObOE0dOhZ $JD $FVRR $DNUT $YETI $CYBR $VERU $HMC $BLDE $TPR $ENTG $HOOK $AQN $NICE $CRL $TNK $USFD $RVLP $HIMX $BAYRY $ATHM $ALT $DRIO $SOHO $SANW $RWLK $BFLY $HUT $PGTI $KOPN $UTZ $CMMB $VRME $SDIG $PKI $TAST $BWEN $GERN $VNRX… https://t.co/yJX909k2ai

      @DeItaone
      DeItaone

      Upgrades $MU $CRL $VOYA $RITM $CBOE https://t.co/eAzzXmWAk3 https://t.co/7XgMb6gMMZ

        @eWhispers
        eWhispers

        Bigger-than-usual #earnings moves today from $PLTK $CRTO $KPTI $ZG $PRG $ATVI $CERS $BCRX $TCS $SGRY $MDXG $LIVN $FMC $CPRI $MG $SMG $EXEL $CRL https://t.co/1pgojKC5HH https://t.co/qlo927tmnf

          @eWhispers
          eWhispers

          #earnings before the open https://t.co/lObOE0dgsr $CVS $NCLH $BCRX $EXPI $MAR $CWH $DISCA $AUPH $CPRI $FUN $CVE $WING $AMRN $SMG $ATY $AAWW $HUM $SPR $HZNP $SHOO $TUP $CLVS $LL $SUN $IONS $GTHX $SID $BWA $EAT $EVRI $CDW $MCS $EXC $CRL $PBI $RADA $VSH $ATH $HFC $EMR $JLL $ETR https://t.co/DGjRvr2fMH

            MarketWatch

            Orphazyme stock plunges after receiving CRL from FDA after review of NPC treatment - MarketWatch

            Analysts Recommendations

            Bullish

            Buy

            Strong Buy

            Buy

            Hold

            Sell

            Strong Sell

            Day Range

            310.52USD
            327.23USD

            52 Week Range

            146.19USD
            379.63USD

            Market Cap

            15.06BUSD

            lock-imagelock-image

            Get Full Access with Profit PRO

            See which Billionaires own this investment

            About

            General Information

            Type

            Common Stock

            Exchange

            NYSE

            Currency Code

            USD

            Currency Name

            US Dollar

            Country Name

            USA

            Country ISO

            US

            ISIN

            US1598641074

            CUSIP

            159864107

            Sector

            Healthcare

            Industry

            Diagnostics & Research

            Fiscal Year End

            December

            IPO date

            -

            Updated At

            -

            Highlights

            PE Ratio

            341.65

            PEG Ratio

            0.13

            Book Value

            67.40

            Dividend Share

            -

            Dividend Yield

            -

            Earnings Share

            0.92

            Wall Street Target Price

            350.64

            EPS Estimate Current Year

            11.47

            EPS Estimate Next Year

            12.97

            EPS Estimate Current Quarter

            2.9724

            EPS Estimate Next Quarter

            3.3288

            Most Recent Quarter

            -

            Profitability

            Revenue TTM

            3,976,867,072

            Gross Profit TTM

            1,395,820,032

            EBITDA

            909,380,992

            Profit Margin

            1.01%

            Return On Assets TTM

            4.74%

            Return On Equity TTM

            1.27%

            Revenue Per Share TTM

            82.001

            Qtly Revenue Growth YOY

            -2.20%

            Diluted Eps TTM

            0.92

            Qtly Earnings Growth YOY

            523.60%

            Valuation

            Trailing PE

            341.65

            Forward PE

            24

            Price Sales TTM

            3.7873

            Price Book MRQ

            4.6673

            Enterprise Value Revenue

            4

            Enterprise Value EBITDA

            60

            Peers analysis

            • WuXi AppTec Co. Ltd
              WUXIFWuXi AppTec Co. Ltd

              23.77

              0.00%
            • Natera Inc
              NTRANatera Inc

              274.16

              -5.81%
            • Waters Corporation
              WATWaters Corporation

              440.45

              -3.77%
            • Agilent Technologies Inc
              AAgilent Technologies Inc

              170.00

              -3.35%
            • Danaher Corporation
              DHRDanaher Corporation

              221.32

              -2.87%
            • Lonza Group AG
              LZAGYLonza Group AG

              77.00

              -2.70%
            • Thermo Fisher Scientific Inc
              TMOThermo Fisher Scientific Inc

              673.31

              -2.50%
            • IDEXX Laboratories Inc
              IDXXIDEXX Laboratories Inc

              673.65

              -2.44%
            • Lonza Group Ltd
              LZAGFLonza Group Ltd

              775.12

              -2.29%
            • IQVIA Holdings Inc
              IQVIQVIA Holdings Inc

              245.82

              -1.80%

            FAQs

            What is Charles River Laboratories stock price today?

            What is Charles River Laboratories stock ticker?

            Is CRL stock price going up?

            What is the analyst recommendation for CRL?

            What is CRL market cap?

            Does CRL release financial reports?

            When is CRL next earnings date?

            What were CRL Earnings for the last quarter?

            What was CRL Revenue for the last quarter?

            What was CRL Net Income for the last quarter?

            Does CRL pay dividends?

            How many employees does CRL have?

            What is CRL EBITDA?

            How to buy CRL stocks?

            Should I invest in CRL stock?